series-b
Stage
2018
Founded
4
Investors
About
Ochre Bio is a biotechnology company focused on developing RNA therapies for chronic liver diseases. The company uses a combination of genomic deep phenotyping, precision RNA medicine, and testing to address liver health challenges, with a goal of reducing the need for liver transplants.
Explore Ochre Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.